Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 540 - per page Previous page Next page
Order by
Seeking licensing opportunities for the UK hospital market More
Cellophil (TM) is particularly designed for optical lenses, drug delivery and also may be used as additive for food and cosmetics or as fiber for fabrics. More
5 and 10 mg Donepezil as well as 4 and 8 mg Ondansetron are under final development using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
Novel effective treatment for Fibromyalgia More
SALINUMâ„¢ is a saliva substitute, indicated for the relief of symptoms of dry mouth, or xerostomia. More
Delivery technologies for oral, topical and transdermal products which could be applicable to the consumer healthcare arena More
Colostrinin is a proline-rich polypeptide complex produced from colostrum and is under development as a neutraceutical treatment for 'the prevention of cognitive decline' in both humans and animals. More
Decapinolâ„¢ rinse contains a cationic surfactant Delmopinol Hydrochloride 2mg/ml; Decapinol rinse has a unique mode of action, which prevents the attachment as well as the adherence of plaque bacteria to the teeth, gingiva and to itself. More
Hyaluronan based gel for prevention and reduction of adhesion formation in the abdominal pelvic area More
UR-1505 is being developed for the topical treatment of psoriasis and atopic dermatitis More
Displaying 11..20 of 540 - per page Previous page Next page
Order by
Partnering consultation free of charge
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us